Szela Mary T

Insider profile

Performance

Overall performance
2.0

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 8% 68% 82%
Transactions
11 73% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return -23%
Success rate 73%
Average holding period 220
Transactions 28
Szela Mary T's trades of TriSalus Life Sciences Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-18 2026-05-15 B Purchase
70,984 -3.3%
22.36
US$1,920,863
70,984 -3.3% 22.36 US$1,920,863
2026-03-20 2026-03-17 S Sale
11,530 +11.2%
354.31
US$4,892,299
11,530 +11.2% 354.31 US$4,892,299
2026-03-20 2026-03-11 S Sale
64,078 +27.4%
219.39
US$2,821,980
64,078 +27.4% 219.39 US$2,821,980
2026-02-23 2026-02-23 B Purchase
30,487 +4.1%
4.10
US$124,997
30,487 +4.1% 4.10 US$124,997
2025-01-31 2025-01-30 B Purchase
5,010 +1.1%
5.28
US$26,453
5,010 +1.1% 5.28 US$26,453
2025-01-31 2025-01-29 B Purchase
5,030 +1.2%
5.03
US$25,301
5,030 +1.2% 5.03 US$25,301
2025-01-29 2025-01-28 B Purchase
4,716 +1.1%
5.12
US$24,146
4,716 +1.1% 5.12 US$24,146
2025-01-29 2025-01-27 B Purchase
4,826 +1.1%
5.42
US$26,157
4,826 +1.1% 5.42 US$26,157
2024-09-13 2024-09-13 B Purchase
6,000 +1.6%
5.00
US$30,000
6,000 +1.6% 5.00 US$30,000
2024-09-13 2024-09-13 B Purchase
1,295 +0.3%
4.83
US$6,255
1,295 +0.3% 4.83 US$6,255
2024-09-13 2024-09-12 B Purchase
7,520 +2.0%
5.20
US$39,104
7,520 +2.0% 5.20 US$39,104
2024-09-12 2024-09-10 B Purchase
5,000 +1.4%
4.97
US$24,850
5,000 +1.4% 4.97 US$24,850
2020-06-24 2020-06-22 S Sale
54,997 -100.0%
17.58
US$966,759
54,997 -100.0% 17.58 US$966,759